Answers are grounded in this paper and cite their sources.
The mean serum complement titers of patients with various neoplastic diseases did not differ significantly from that for normal adults. The range of complement values was greater among cancer patients than among normals, but the erratic titers did not appear to be related to clinical status. No depression of human complement titer was observed following the clinical use of nitrogen mustard and x-ray in maximal dosage. Human complement is inactivated by high concentrations of nitrogen mustard in vitro, but not by concentrations in the range which is achieved in clinical usage.
No takes yet. Share an insight, caveat, or question.
Southam et al. (1951) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: